WAY Stock Card: Scores, Risk & Setup | Stoxcraft

Waystar Holding Corp.

Health

Performance

6.1

Risk

Sell

Buy

Curious about the Scores? Learn more.

Waystar Holding Corp. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

22.09.2026

Trouble brewing. Volatility and pressure rising.

15.09.2026

Barely upright. Still chaotic, but slowly finding some balance.

15.09.2026

Slight bounce. Could be noise – or a comeback brewing.

01.04.2026

Health turning shaky. Something under the hood’s off.

WAY

Waystar Holding Corp.

25.71

+0.19%

6.1

Sell

Buy

© Stoxcraft

Waystar Holding Corp.

Waystar Holding Corp. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Waystar Holding Corp. do? Business model and key facts

Get the full picture of Waystar Holding Corp.: what it builds, where it operates, and how it makes money.

Waystar Holding Corp. Profile

Sector: Healthcare

Industry: Medical - Healthcare Information Services

Employees (FY): 1700

Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.

Company facts

Matthew J. Hawkins

CEO

1700

Employees worldwide

Performance

-31.8%

Last 12 months

Growth

$1.10B

Revenue year

$112.09M

Net income

Valuation

$4.92B

Market Cap

51.98

Price/Earnings Ratio

Stocks related to Waystar Holding Corp.

Selected based on industry alignment and relative market positioning.

HNGE

Hinge Health, Inc.

94.45

-0.47%

6.3

Sell

Buy

© Stoxcraft

Hinge Health, Inc.

HQY

HealthEquity, Inc.

94.52

-0.65%

3.8

Sell

Buy

© Stoxcraft

HealthEquity, Inc.

BTSG

BrightSpring Health Services, Inc. Common Stock

55.86

-1.62%

8.2

Sell

Buy

© Stoxcraft

BrightSpring Health Services, Inc. Common Stock

DOCS

Doximity, Inc.

26.84

+2.80%

8.0

Sell

Buy

© Stoxcraft

Doximity, Inc.

PRVA

Privia Health Group, Inc.

19.54

-1.56%

6.2

Sell

Buy

© Stoxcraft

Privia Health Group, Inc.

Events and news impacting Waystar Holding Corp. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Toroshi watches Eli Lilly and Regeneron face off in a low-poly healthcare arena, visualizing the Biotechnology vs Drug Manufacturers comparison and 2–1 result.

18 September 2026

Biotechnology vs. Drug Manufacturers: whose Health Score holds up better?

18 September 2026

5 min 27 sec read

Biotechnology vs. Drug Manufacturers: whose Health Score holds up better?

Biotechnology has the higher-scoring flagship stock, but its industry-wide Health Score average trails Drug Manufacturers badly. Here's which one actually wins.

HypeMeter-img

Slightly Bullish

Toroshi stands before a performance leaderboard dominated by gold and copper stocks with perfect 10.0 scores, while cybersecurity, biotech, and asset management names also rank near the top.

These 10 stocks have the highest performance scores right now

5 min 58 sec read

These 10 stocks have the highest performance scores right now

Copper and gold miners are dominating this week's Performance Score rankings. See which 10 stocks lead the pack.

HypeMeter-img

Slightly Bullish

Moderna, Tempus AI and Adecoagro stocks surge in Triple Boost race

3 stock risers this week: Moderna, Tempus AI, and Adecoagro soar

4 min 6 sec read

3 stock risers this week: Moderna, Tempus AI, and Adecoagro soar

A cancer-drug breakthrough sent Moderna up 124% and Tempus AI soaring this week. Adecoagro rounds out the trio with a record EBITDA quarter.

HypeMeter-img

Toroshi watches a stable green Moderna cancer-vaccine science core inside an overheating red market chamber, showing a real biotech breakthrough amid extreme stock-price volatility.

Moderna (MRNA) gives back 20% of its historic cancer-vaccine rally

Moderna (MRNA) gives back 20% of its historic cancer-vaccine rally

Moderna soared 177% on cancer vaccine data, then gave back over 20% the next day. The Health Score never believed the story.

HypeMeter-img

Slightly Bullish

Toroshi inspects an overheated ABCL biotech engine glowing red at extreme momentum while weaker health warnings flash beside calmer ADPT and RCUS systems.

ABCL stock forecast: up 68% and overbought, but the score says sell

5 min 41 sec read

ABCL stock forecast: up 68% and overbought, but the score says sell

ABCL is up nearly 70% in a month and deep in overbought territory. Its Health Score of 1.8 tells a very different story than the chart.

HypeMeter-img

Stock Market Winners of the Week: ABCL, HTZ &amp; NBIS

Riser of the week: ABCL, HTZ and NBIS surge on earnings

5 min 5 sec read

Riser of the week: ABCL, HTZ and NBIS surge on earnings

A drug win, a short squeeze and an AI earnings beat sent ABCL, HTZ and NBIS soaring this week. Their Stoxcraft scores tell three different stories.

HypeMeter-img

Toroshi Stoxcraft mascot — Innodata INOD insider selling 2026 score analysis

Innodata (INOD): new CFO, $51M deal, and $90M in insider sales

8 min 17 sec read

Innodata (INOD): new CFO, $51M deal, and $90M in insider sales

Innodata's CEO sold over $90M in stock this spring. The company just landed a new $51M Big Tech deal. Those two facts should not be able to coexist this calmly.

HypeMeter-img

Slightly Bullish

Toroshi controls a glowing ASML mech in a high-tech bay while KLAC, LRCX, and AMAT racing machines speed past in the background.

ASML has the EUV monopoly. So why is it losing to its suppliers?

6 min 10 sec read

ASML has the EUV monopoly. So why is it losing to its suppliers?

ASML is the only company on Earth that builds EUV lithography machines at scale. Its peers have still outrun it. Wednesday's Q2 earnings will decide if the monopoly premium is justified or just expensive.

HypeMeter-img

Slightly Bullish

Toroshi scans two RPG-style score cards, with RKLB shown as a glass cannon rocket build and CRWV as a weakened data-center mage with thin stats across the board.

When RKLB and CRWV insiders cash out: reading the rough week

6 min 18 sec read

When RKLB and CRWV insiders cash out: reading the rough week

Insiders at two high-growth stocks dumped nearly $300M in shares. Both stocks tumbled the same week. The scores show one situation is far more dangerous than the other.

HypeMeter-img

Slightly Bullish

Toroshi Stoxcraft mascot Honeywell HON aerospace spinoff analysis

Honeywell (HON) didn't crash. Its aerospace business just left the building.

Company Spotlight

4 min 37 sec read

Honeywell (HON) didn't crash. Its aerospace business just left the building.

HON is down 46% in a month on every price chart right now. The stock is 8.3% below its 52-week high. Those two facts don't match unless you know what happened on June 29.

HypeMeter-img

Toroshi Forging Stock Split Candidates

Upcoming stock splits in 2026: what the scores say about FICO, Costco, and AutoZone

6 min 18 sec read

Upcoming stock splits in 2026: what the scores say about FICO, Costco, and AutoZone

Three stocks are 2026's favorite stock split candidates. FICO, Costco, and AutoZone all trade above $900 a share. But only one has the fundamentals to match the hype.

HypeMeter-img

Toroshi Carrying Micron’s $100B Memory Cargo Through Market Volatility

The Micron (MU) paradox: record contracts, falling stock

Company Spotlight

5 min 19 sec read

The Micron (MU) paradox: record contracts, falling stock

Micron just locked up $100B in future revenue. The stock cratered anyway. Here's the disconnect nobody's pricing in.

HypeMeter-img

Toroshi Managing Hyperscaler AI Spending in an RTS War Room

Hyperscaler earnings Q2 2026: what score gaps reveal before the print

Tech & Innovation

3 min 50 sec read

Hyperscaler earnings Q2 2026: what score gaps reveal before the print

Four hyperscalers report Q2 results July 22 to 30. Combined AI spending tops $650B this year. The scores say this isn't one stor, it's four different setups.

HypeMeter-img

Slightly Bullish

Toroshi presents five stock fighters labeled ACMR, MXL, HUM, BJRI, and SN in a futuristic low-poly arena.

June's 5 strongest-trending stocks: the fundamentals aren't equal

5 min 24 sec read

June's 5 strongest-trending stocks: the fundamentals aren't equal

Humana just hit a 52-week high. Analysts keep raising price targets. Its performance score still says something's off.

HypeMeter-img

Slightly Bullish

CrowdStrike 4-for-1 Stock Split Racing Through a Split Portal

CrowdStrike's 4-for-1 split lands tomorrow: here's what CRWD's data shows before it trades lower

Company Spotlight

5 min 44 sec read

CrowdStrike's 4-for-1 split lands tomorrow: here's what CRWD's data shows before it trades lower

CrowdStrike splits today. Four shares for every one you hold. The data is the strongest it's been in months.

HypeMeter-img

Slightly Bullish

Waystar Holding Corp. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.